Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M; Diabetes, Obesity & Metabolism, 2010, vol. 12, issue 8, p 716, ISSN 14631326. ISBN 14631326.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef